How many employees does Agios Pharmaceuticals, Inc. have?

Agios Pharmaceuticals, Inc. reported 539 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 12, 2026. That is up 10.9% from a year earlier.

What is Agios Pharmaceuticals, Inc.'s revenue per employee?

Agios Pharmaceuticals, Inc. brought in $54.0M of revenue in fiscal Dec 2025, which is $100K per employee. That ranks 91 of 108 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Agios Pharmaceuticals, Inc. employees and revenue per employee

AGIO · Biotechnology · $1.90B market cap

Agios Pharmaceuticals, Inc. had 539 employees at the end of fiscal Dec 2025, up 10.9% from a year earlier. Revenue for the year was $54.0M, up 48.0% from a year earlier, or $100K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

539

+10.9% YoY

Revenue

$54.0M

+48.0% YoY

Revenue / employee

$100K

Peer median $459K

Rank in industry

91 of 108

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016

Hover a year for the numbers.

AGIO employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	539	$54.0M	$100K	+10.9%	+48.0%
Dec 2024	486	$36.5M	$75K	+26.9%	+36.1%
Dec 2023	383	$26.8M	$70K	-1.5%	+88.4%
Dec 2022	389	$14.2M	$37K	—	—
Dec 2019	536	$118M	$220K	+11.2%	+24.9%
Dec 2018	482	$94.4M	$196K	+26.2%	+119.4%
Dec 2017	382	$43.0M	$113K	+33.1%	-38.5%
Dec 2016	287	$69.9M	$244K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Agios Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
FENC Fennec Pharmaceuticals Inc.	35	$44.6M	$1.28M	Hiring into decline
NKTR Nektar Therapeutics	63	$55.2M	$877K	Hiring into decline
ENTA Enanta Pharmaceuticals, Inc.	120	$65.3M	$544K	Contracting
TNGX Tango Therapeutics, Inc.	137	$62.4M	$455K	Leaner
SEPN Septerna Inc	130	$46.0M	$353K	Efficient growth
PTGX Protagonist Therapeutics, Inc.	132	$46.0M	$349K	Hiring into decline
NUVB Nuvation Bio Inc.	298	$62.9M	$211K	Efficient growth
OCUL Ocular Therapeutix, Inc.	325	$51.8M	$159K	Hiring into decline
AGIO Agios Pharmaceuticals, Inc.	539	$54.0M	$100K	Efficient growth

Every Healthcare company

Questions about Agios Pharmaceuticals, Inc.

How many employees does Agios Pharmaceuticals, Inc. have?: Agios Pharmaceuticals, Inc. reported 539 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 12, 2026. That is up 10.9% from a year earlier.
What is Agios Pharmaceuticals, Inc.'s revenue per employee?: Agios Pharmaceuticals, Inc. brought in $54.0M of revenue in fiscal Dec 2025, which is $100K per employee. That ranks 91 of 108 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare AGIO with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Agios Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 12, 2026. This is data, not a recommendation to buy or sell AGIO.